Follow-up results of isoniazid chemoprophylaxis during biological therapy in Colombia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s00296-015-3249-6.pdf
Reference20 articles.
1. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N et al (2010) Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 87:385–395
2. Brassard P, Kezouh A, Suissa S (2006) Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 43:717–722
3. Xie X, Li F, Chen JW, Wang J (2014) Risk of tuberculosis infection in anti-TNF-α biological therapy: from bench to bedside. J Microbiol Immunol Infect 47:268–274
4. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL (2011) Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 306:2331–2339
5. Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW et al (2013) Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 72:37–42
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lessons learned from chemoprophylaxis programmes for neglected diseases and diseases of poverty in Latin America: a systematic review;Caderno Pedagógico;2024-07-16
2. Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review;Revista da Sociedade Brasileira de Medicina Tropical;2024
3. Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse;Rheumatology;2023-06-22
4. Tuberculosis and Biologic Therapies;Clinics in Chest Medicine;2019-12
5. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India;International Journal of Rheumatic Diseases;2018-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3